Brainsway Ltd (BWAY) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.020x

Based on the latest financial reports, Brainsway Ltd (BWAY) has a cash flow conversion efficiency ratio of 0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA1.39 Million ≈ $3.72K USD) by net assets (ILA70.06 Million ≈ $187.84K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Brainsway Ltd (BWAY) net asset quality to measure how much of total assets are equity-financed.

Brainsway Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Brainsway Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Brainsway Ltd (BWAY) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Brainsway Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Brainsway Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Jinyuan Cement Co Ltd
SHE:000546
0.034x
AGI Greenpac Limited
NSE:AGI
-0.038x
Dat Xanh Real Estate Service Contructions Corp
VN:DXG
0.024x
Guangdong Xiongsu Technology Group Co Ltd
SHE:300599
0.001x
ZF Commercial Vehicle Control Systems India Limited
NSE:ZFCVINDIA
0.015x
Hap Seng Plantations Holdings Bhd
KLSE:5138
0.001x
Shenzhen Etmade Automatic Equipment
SHE:300812
0.067x
Enterprise Bancorp Inc
NASDAQ:EBTC
0.014x

Annual Cash Flow Conversion Efficiency for Brainsway Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Brainsway Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Brainsway Ltd worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ILA62.31 Million
≈ $167.06K
ILA10.30 Million
≈ $27.61K
0.165x +435.19%
2023-12-31 ILA41.58 Million
≈ $111.48K
ILA1.28 Million
≈ $3.44K
0.031x +114.36%
2022-12-31 ILA45.40 Million
≈ $121.71K
ILA-9.76 Million
≈ $-26.16K
-0.215x -1494.00%
2021-12-31 ILA57.32 Million
≈ $153.68K
ILA884.00K
≈ $2.37K
0.015x +121.08%
2020-12-31 ILA19.63 Million
≈ $52.64K
ILA-1.44 Million
≈ $-3.85K
-0.073x +75.55%
2019-12-31 ILA24.22 Million
≈ $64.93K
ILA-7.24 Million
≈ $-19.42K
-0.299x +44.89%
2018-12-31 ILA6.95 Million
≈ $18.64K
ILA-3.77 Million
≈ $-10.12K
-0.543x -99.13%
2017-12-31 ILA12.72 Million
≈ $34.10K
ILA-3.47 Million
≈ $-9.29K
-0.273x -16.72%
2016-12-31 ILA10.29 Million
≈ $27.58K
ILA-2.40 Million
≈ $-6.44K
-0.233x +33.85%
2015-12-31 ILA12.89 Million
≈ $34.57K
ILA-4.55 Million
≈ $-12.20K
-0.353x -44.97%
2014-12-31 ILA15.58 Million
≈ $41.76K
ILA-3.79 Million
≈ $-10.17K
-0.244x -50.97%
2013-12-31 ILA14.65 Million
≈ $39.28K
ILA-2.36 Million
≈ $-6.34K
-0.161x +74.07%
2012-12-31 ILA9.01 Million
≈ $24.15K
ILA-5.60 Million
≈ $-15.02K
-0.622x --

About Brainsway Ltd

TA:BWAY Israel Medical Devices
Market Cap
$496.09 Million
ILA185.04 Billion ILA
Market Cap Rank
#12070 Global
#133 in Israel
Share Price
ILA4718.00
Change (1 day)
+5.90%
52-Week Range
ILA1981.00 - ILA5074.00
All Time High
ILA5074.00
About

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, sc… Read more